Snake Venom Phospholipases A2: A Novel Tool Against Bacterial Diseases

E-ISSN： 1875-533x|19|36|6150-6162

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.19, Iss.36, 2012-12, pp. : 6150-6162

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antitumoral Potential of Snake Venom Phospholipases A2 and Synthetic Peptides

Current Pharmaceutical Biotechnology, Vol. 17, Iss. 14, 2016-11 ,pp. : 1201-1212

Bentham Science Publishers

Access to resources Recommend Favorite

Snake Venom Phospholipase A2 Inhibitors: Medicinal Chemistry and Therapeutic Potential

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 8, 2007-04 ,pp. : 743-756

Bentham Science Publishers

Access to resources Recommend Favorite

Group VI Phospholipases A2: Homeostatic Phospholipases with Significant Potential as Targets for Novel Therapeutics

Current Drug Targets, Vol. 9, Iss. 8, 2008-08 ,pp. : 683-697

Bentham Science Publishers

Access to resources Recommend Favorite

Antimicrobial Peptides as an Opportunity Against Bacterial Diseases

Current Medicinal Chemistry, Vol. 22, Iss. 14, 2015-05 ,pp. : 1665-1677

Bentham Science Publishers

Access to resources Recommend Favorite

In vitro activities of small peptides from snake venom against clinical isolates of drug-resistant Mycobacterium tuberculosis

By Xie J.P. Yue J. Xiong Y.L. Wang W.Y. Yu S.Q. Wang H.H.

International Journal of Antimicrobial Agents, Vol. 22, Iss. 2, 2003-08 ,pp. : 172-174

Elsevier

Access to resources Recommend Favorite